JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.3B |
| 2 |
McDonald's
MCD
|
+$2.2B |
| 3 |
Microsoft
MSFT
|
+$2.07B |
| 4 |
NVIDIA
NVDA
|
+$1.94B |
| 5 |
Goldman Sachs
GS
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$2.77B |
| 2 |
Broadcom
AVGO
|
+$1.88B |
| 3 |
TSMC
TSM
|
+$1.18B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.14B |
| 5 |
Danaher
DHR
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.59% |
| 2 | Healthcare | 9.24% |
| 3 | Consumer Discretionary | 9.21% |
| 4 | Financials | 9.1% |
| 5 | Industrials | 7.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
Kimco Realty Corp 7.25% Class N Preferred Stock
KIM.PRN
$85.4M
| $3.53M | ﹤0.01% |
57,480
-4,520
| -7% | -$262K |
|
3377
First Trust Short Duration Managed Municipal ETF
FSMB
$628M
| $3.52M | ﹤0.01% |
176,086
+11,210
| +7% | +$224K |
|
3378
Skyward Specialty Insurance
SKWD
$2.42B
| $3.52M | ﹤0.01% |
86,302
+21,346
| +33% | +$827K |
|
3379
Real Brokerage
REAX
$523M
| $3.51M | ﹤0.01% |
631,916
+542,653
| +608% | +$3.08M |
|
3380
ADT
ADT
$5.47B
| $3.5M | ﹤0.01% |
484,769
+100,134
| +26% | +$735K |
|
|
ONTF
3381
DELISTED
ON24
ONTF
| $3.5M | ﹤0.01% |
572,416
-10,614
| -2% | -$65.6K |
|
3382
PUT
Paychex
PAYX
$43.4B
| $3.5M | ﹤0.01% |
+26,100
| New | +$3.31M |
|
3383
UFP Technologies
UFPT
$2.49B
| $3.5M | ﹤0.01% |
11,048
-499
| -4% | -$159K |
|
3384
Seadrill
SDRL
$3B
| $3.5M | ﹤0.01% |
88,039
+17,955
| +26% | +$826K |
|
3385
CALL
Match Group
MTCH
$8.71B
| $3.5M | ﹤0.01% |
92,400
| – | – |
|
3386
PUT
FIVE9
FIVN
$2.47B
| $3.48M | ﹤0.01% |
121,300
| – | – |
|
3387
JPMorgan Equity Focus ETF
JPEF
$2.07B
| $3.48M | ﹤0.01% |
53,117
+15,728
| +42% | +$994K |
|
|
IRBT
3388
DELISTED
iRobot
IRBT
| $3.48M | ﹤0.01% |
400,427
+386,189
| +2,712% | +$3.34M |
|
|
DNB
3389
DELISTED
Dun & Bradstreet
DNB
| $3.46M | ﹤0.01% |
300,904
-53,125
| -15% | -$590K |
|
3390
PUT
Louisiana-Pacific
LPX
$5.17B
| $3.46M | ﹤0.01% |
32,200
| – | – |
|
3391
PUT
Aon
AON
$75.5B
| $3.46M | ﹤0.01% |
10,000
| – | – |
|
3392
PUT
Neurocrine Biosciences
NBIX
$15.5B
| $3.46M | ﹤0.01% |
30,000
| – | – |
|
3393
Privia Health
PRVA
$2.81B
| $3.43M | ﹤0.01% |
188,384
+14,641
| +8% | +$279K |
|
3394
PUT
Warby Parker
WRBY
$3.2B
| $3.43M | ﹤0.01% |
210,000
-15,000
| -7% | -$226K |
|
3395
CALL
Vaxcyte
PCVX
$8.64B
| $3.43M | ﹤0.01% |
+30,000
| New | +$2.7M |
|
3396
Atlantic Union Bankshares
AUB
$6.12B
| $3.43M | ﹤0.01% |
90,957
-2,085
| -2% | -$78.5K |
|
3397
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $3.42M | ﹤0.01% |
34,394
-67,656
| -66% | -$6.61M |
|
3398
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.93B
| $3.42M | ﹤0.01% |
181,761
+136,330
| +300% | +$2.54M |
|
3399
WisdomTree
WT
$3.46B
| $3.42M | ﹤0.01% |
342,104
-318,090
| -48% | -$3.23M |
|
3400
4D Molecular Therapeutics
FDMT
$673M
| $3.42M | ﹤0.01% |
315,983
-29,790
| -9% | -$494K |
|
Similar funds
JP Morgan Chase's Q3 2024 Portfolio in Review
As of Q3 2024, JP Morgan Chase held 7,854 positions worth $1.32T, up 7.9% from $1.22T the previous quarter. Its ten largest holdings account for 23% of the portfolio.
JP Morgan Chase's Q3 2024 filing shows 533 new, 3,476 increased, 2,341 reduced and 444 closed positions. Its largest new stake was Smurfit Westrock: 4,472,396 shares worth $221M. The largest sale was Advanced Micro Devices, an estimated $2.77B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- JP Morgan Chase's largest Q3 2024 buy was Smurfit Westrock: 4,472,396 shares worth $221M.
- JP Morgan Chase added most to iShares Broad USD High Yield Corporate Bond ETF in Q3 2024, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q3 2024 reduction was Advanced Micro Devices, cutting an estimated $2.77B.
- JP Morgan Chase fully exited WestRock Company in Q3 2024, selling an estimated $320M.
- JP Morgan Chase's ten largest holdings make up 23% of its $1.32T portfolio in Q3 2024.
- JP Morgan Chase opened 533 new positions and closed 444 in Q3 2024.
- JP Morgan Chase's portfolio value rose 7.9% quarter-over-quarter to $1.32T.
Based on JP Morgan Chase's 13F filing for Q3 2024, filed 8 Nov 2024.